AHAs
This article was originally published in The Rose Sheet
Executive Summary
FDA's completed alpha hydroxy acid clinical trials are expected to be released in a final report by early September. The sunburn cell and minimal erythema dose studies demonstrated similar effects to those found in earlier studies conducted by the Cosmetic, Toiletry and Fragrance Association, which showed a slight but not troubling increase in skin's sensitivity to sunlight following application of 10% glycolic acid versus other vehicles. The agency's thymidine dimer results were not found to be statistically significant. FDA announced plans to begin the tests in late 1996 after CTFA's results led to the Cosmetic Ingredient Review's "safe as used" with qualifications ruling for the ingredient group